Consistently with its functional role and further reinforcing its association with MSLN, elevated MMP-7 expression has been reported across several MSLN-positive malignancies, including pancreatic, breast, colorectal, ovarian, and NSCL cancers [42, 43, 49–51]. This evidence concerns the gene MSLN and cancer.